Hypomagnesemia, Hypocalcemia, and Tubulointerstitial Nephropathy Caused by Claudin-16 Autoantibodies

Significant Statement Chronic hypomagnesemia is commonly due to diarrhea, alcoholism, and drugs; more rarely, genetic defects in the effectors of renal magnesium reabsorption are responsible. The authors report on an adult patient with acquired severe hypomagnesemia, hypocalcemia, and tubulointersti...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of the American Society of Nephrology 2022-07, Vol.33 (7), p.1402-1410
Hauptverfasser: Figueres, Lucile, Bruneau, Sarah, Prot-Bertoye, Caroline, Brideau, Gaëlle, Néel, Mélanie, Griveau, Camille, Cheval, Lydie, Bignon, Yohan, Dimitrov, Jordan, Dejoie, Thomas, Ville, Simon, Kandel-Aznar, Christine, Moreau, Anne, Houillier, Pascal, Fakhouri, Fadi
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1410
container_issue 7
container_start_page 1402
container_title Journal of the American Society of Nephrology
container_volume 33
creator Figueres, Lucile
Bruneau, Sarah
Prot-Bertoye, Caroline
Brideau, Gaëlle
Néel, Mélanie
Griveau, Camille
Cheval, Lydie
Bignon, Yohan
Dimitrov, Jordan
Dejoie, Thomas
Ville, Simon
Kandel-Aznar, Christine
Moreau, Anne
Houillier, Pascal
Fakhouri, Fadi
description Significant Statement Chronic hypomagnesemia is commonly due to diarrhea, alcoholism, and drugs; more rarely, genetic defects in the effectors of renal magnesium reabsorption are responsible. The authors report on an adult patient with acquired severe hypomagnesemia, hypocalcemia, and tubulointerstitial nephropathy, with rapidly progressing kidney injury. In in vivo and in vitro studies, they found evidence of a causal link between the patient’s condition and autoantibodies against claudin-16, a transmembrane paracellular protein involved in renal magnesium absorption. The patient was subsequently diagnosed with a renal carcinoma that expressed a high level of claudin-16 mRNA. Pathogenic claudin-16 autoantibodies represent a novel autoimmune cause of specific renal tubular transport disturbances and tubulointerstitial nephropathy. Screening for autoantibodies targeting claudin-16 and potentially other renal magnesium transporters or channels may be warranted in patients with acquired unexplained hypomagnesemia. Background Chronic hypomagnesemia is commonly due to diarrhea, alcoholism, and drugs. More rarely, it is caused by genetic defects in the effectors of renal magnesium reabsorption. Methods In an adult patient with acquired severe hypomagnesemia, hypocalcemia, tubulointerstitial nephropathy, and rapidly progressing kidney injury, similarities between the patient’s presentation and features of genetic disorders of renal magnesium transport prompted us to investigate whether the patient had an acquired autoimmune cause of renal magnesium wasting. To determine if the patient’s condition might be explained by autoantibodies directed against claudin-16 or claudin-19, transmembrane paracellular proteins involved in renal magnesium absorption, we conducted experiments with claudin knockout mice and transfected mouse kidney cells expressing human claudin-16 or claudin-19. We also examined effects on renal magnesium handling in rats given intravenous injections of IgG purified from sera from the patient or controls. Results Experiments with the knockout mice and in vitro transfected cells demonstrated that hypomagnesemia in the patient was causally linked to autoantibodies directed against claudin-16, which controls paracellular magnesium reabsorption in the thick ascending limb of Henle’s loop. Intravenous injection of IgG purified from the patient’s serum induced a marked urinary waste of magnesium in rats. Immunosuppressive treatment combining plasma excha
doi_str_mv 10.1681/ASN.2022010060
format Article
fullrecord <record><control><sourceid>hal</sourceid><recordid>TN_cdi_hal_primary_oai_HAL_hal_04733822v1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>oai_HAL_hal_04733822v1</sourcerecordid><originalsourceid>FETCH-hal_primary_oai_HAL_hal_04733822v13</originalsourceid><addsrcrecordid>eNqVirFOwzAURS0EoqWwMntFIu2zndhZowqUAXWhe_RSG2Lk2FFsI-XvaQU_wHTPObqEPDLYMlmzXfN-2HLgHBiAhCuyZpUQhSgruD4zlLKQUokVuYvxC4BVXKlbshKV4nVdl2ui22UKI356E81o8Zle_ITu9GvoNT3mPrtgfTJzTDZZdPRgpmEOE6ZhoXvM0Wjan8lh1tYXTNImp4A-2T5oa-I9uflAF83D327I0-vLcd8WA7pumu2I89IFtF3bvHWXBqUSoub8m4n_fH8AfqJSIg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Hypomagnesemia, Hypocalcemia, and Tubulointerstitial Nephropathy Caused by Claudin-16 Autoantibodies</title><source>PubMed Central</source><source>EZB Electronic Journals Library</source><creator>Figueres, Lucile ; Bruneau, Sarah ; Prot-Bertoye, Caroline ; Brideau, Gaëlle ; Néel, Mélanie ; Griveau, Camille ; Cheval, Lydie ; Bignon, Yohan ; Dimitrov, Jordan ; Dejoie, Thomas ; Ville, Simon ; Kandel-Aznar, Christine ; Moreau, Anne ; Houillier, Pascal ; Fakhouri, Fadi</creator><creatorcontrib>Figueres, Lucile ; Bruneau, Sarah ; Prot-Bertoye, Caroline ; Brideau, Gaëlle ; Néel, Mélanie ; Griveau, Camille ; Cheval, Lydie ; Bignon, Yohan ; Dimitrov, Jordan ; Dejoie, Thomas ; Ville, Simon ; Kandel-Aznar, Christine ; Moreau, Anne ; Houillier, Pascal ; Fakhouri, Fadi</creatorcontrib><description>Significant Statement Chronic hypomagnesemia is commonly due to diarrhea, alcoholism, and drugs; more rarely, genetic defects in the effectors of renal magnesium reabsorption are responsible. The authors report on an adult patient with acquired severe hypomagnesemia, hypocalcemia, and tubulointerstitial nephropathy, with rapidly progressing kidney injury. In in vivo and in vitro studies, they found evidence of a causal link between the patient’s condition and autoantibodies against claudin-16, a transmembrane paracellular protein involved in renal magnesium absorption. The patient was subsequently diagnosed with a renal carcinoma that expressed a high level of claudin-16 mRNA. Pathogenic claudin-16 autoantibodies represent a novel autoimmune cause of specific renal tubular transport disturbances and tubulointerstitial nephropathy. Screening for autoantibodies targeting claudin-16 and potentially other renal magnesium transporters or channels may be warranted in patients with acquired unexplained hypomagnesemia. Background Chronic hypomagnesemia is commonly due to diarrhea, alcoholism, and drugs. More rarely, it is caused by genetic defects in the effectors of renal magnesium reabsorption. Methods In an adult patient with acquired severe hypomagnesemia, hypocalcemia, tubulointerstitial nephropathy, and rapidly progressing kidney injury, similarities between the patient’s presentation and features of genetic disorders of renal magnesium transport prompted us to investigate whether the patient had an acquired autoimmune cause of renal magnesium wasting. To determine if the patient’s condition might be explained by autoantibodies directed against claudin-16 or claudin-19, transmembrane paracellular proteins involved in renal magnesium absorption, we conducted experiments with claudin knockout mice and transfected mouse kidney cells expressing human claudin-16 or claudin-19. We also examined effects on renal magnesium handling in rats given intravenous injections of IgG purified from sera from the patient or controls. Results Experiments with the knockout mice and in vitro transfected cells demonstrated that hypomagnesemia in the patient was causally linked to autoantibodies directed against claudin-16, which controls paracellular magnesium reabsorption in the thick ascending limb of Henle’s loop. Intravenous injection of IgG purified from the patient’s serum induced a marked urinary waste of magnesium in rats. Immunosuppressive treatment combining plasma exchange and rituximab was associated with improvement in the patient’s GFR, but hypomagnesemia persisted. The patient was subsequently diagnosed with a renal carcinoma that expressed a high level of claudin-16 mRNA. Conclusions Pathogenic claudin-16 autoantibodies represent a novel autoimmune cause of specific renal tubular transport disturbances and tubulointerstitial nephropathy. Screening for autoantibodies targeting claudin-16, and potentially other magnesium transporters or channels in the kidney, may be warranted in patients with acquired unexplained hypomagnesemia.</description><identifier>ISSN: 1046-6673</identifier><identifier>EISSN: 1533-3450</identifier><identifier>DOI: 10.1681/ASN.2022010060</identifier><identifier>PMID: 35728884</identifier><language>eng</language><publisher>American Society of Nephrology</publisher><subject>Life Sciences</subject><ispartof>Journal of the American Society of Nephrology, 2022-07, Vol.33 (7), p.1402-1410</ispartof><rights>Distributed under a Creative Commons Attribution 4.0 International License</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><orcidid>0000-0003-0618-6187 ; 0000-0002-1552-0725 ; 0000-0002-1473-2064 ; 0000-0001-8536-8995 ; 0000-0002-1473-2064 ; 0000-0001-8536-8995 ; 0000-0002-1552-0725 ; 0000-0003-0618-6187</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,315,781,785,886,27929,27930</link.rule.ids><backlink>$$Uhttps://hal.science/hal-04733822$$DView record in HAL$$Hfree_for_read</backlink></links><search><creatorcontrib>Figueres, Lucile</creatorcontrib><creatorcontrib>Bruneau, Sarah</creatorcontrib><creatorcontrib>Prot-Bertoye, Caroline</creatorcontrib><creatorcontrib>Brideau, Gaëlle</creatorcontrib><creatorcontrib>Néel, Mélanie</creatorcontrib><creatorcontrib>Griveau, Camille</creatorcontrib><creatorcontrib>Cheval, Lydie</creatorcontrib><creatorcontrib>Bignon, Yohan</creatorcontrib><creatorcontrib>Dimitrov, Jordan</creatorcontrib><creatorcontrib>Dejoie, Thomas</creatorcontrib><creatorcontrib>Ville, Simon</creatorcontrib><creatorcontrib>Kandel-Aznar, Christine</creatorcontrib><creatorcontrib>Moreau, Anne</creatorcontrib><creatorcontrib>Houillier, Pascal</creatorcontrib><creatorcontrib>Fakhouri, Fadi</creatorcontrib><title>Hypomagnesemia, Hypocalcemia, and Tubulointerstitial Nephropathy Caused by Claudin-16 Autoantibodies</title><title>Journal of the American Society of Nephrology</title><description>Significant Statement Chronic hypomagnesemia is commonly due to diarrhea, alcoholism, and drugs; more rarely, genetic defects in the effectors of renal magnesium reabsorption are responsible. The authors report on an adult patient with acquired severe hypomagnesemia, hypocalcemia, and tubulointerstitial nephropathy, with rapidly progressing kidney injury. In in vivo and in vitro studies, they found evidence of a causal link between the patient’s condition and autoantibodies against claudin-16, a transmembrane paracellular protein involved in renal magnesium absorption. The patient was subsequently diagnosed with a renal carcinoma that expressed a high level of claudin-16 mRNA. Pathogenic claudin-16 autoantibodies represent a novel autoimmune cause of specific renal tubular transport disturbances and tubulointerstitial nephropathy. Screening for autoantibodies targeting claudin-16 and potentially other renal magnesium transporters or channels may be warranted in patients with acquired unexplained hypomagnesemia. Background Chronic hypomagnesemia is commonly due to diarrhea, alcoholism, and drugs. More rarely, it is caused by genetic defects in the effectors of renal magnesium reabsorption. Methods In an adult patient with acquired severe hypomagnesemia, hypocalcemia, tubulointerstitial nephropathy, and rapidly progressing kidney injury, similarities between the patient’s presentation and features of genetic disorders of renal magnesium transport prompted us to investigate whether the patient had an acquired autoimmune cause of renal magnesium wasting. To determine if the patient’s condition might be explained by autoantibodies directed against claudin-16 or claudin-19, transmembrane paracellular proteins involved in renal magnesium absorption, we conducted experiments with claudin knockout mice and transfected mouse kidney cells expressing human claudin-16 or claudin-19. We also examined effects on renal magnesium handling in rats given intravenous injections of IgG purified from sera from the patient or controls. Results Experiments with the knockout mice and in vitro transfected cells demonstrated that hypomagnesemia in the patient was causally linked to autoantibodies directed against claudin-16, which controls paracellular magnesium reabsorption in the thick ascending limb of Henle’s loop. Intravenous injection of IgG purified from the patient’s serum induced a marked urinary waste of magnesium in rats. Immunosuppressive treatment combining plasma exchange and rituximab was associated with improvement in the patient’s GFR, but hypomagnesemia persisted. The patient was subsequently diagnosed with a renal carcinoma that expressed a high level of claudin-16 mRNA. Conclusions Pathogenic claudin-16 autoantibodies represent a novel autoimmune cause of specific renal tubular transport disturbances and tubulointerstitial nephropathy. Screening for autoantibodies targeting claudin-16, and potentially other magnesium transporters or channels in the kidney, may be warranted in patients with acquired unexplained hypomagnesemia.</description><subject>Life Sciences</subject><issn>1046-6673</issn><issn>1533-3450</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNqVirFOwzAURS0EoqWwMntFIu2zndhZowqUAXWhe_RSG2Lk2FFsI-XvaQU_wHTPObqEPDLYMlmzXfN-2HLgHBiAhCuyZpUQhSgruD4zlLKQUokVuYvxC4BVXKlbshKV4nVdl2ui22UKI356E81o8Zle_ITu9GvoNT3mPrtgfTJzTDZZdPRgpmEOE6ZhoXvM0Wjan8lh1tYXTNImp4A-2T5oa-I9uflAF83D327I0-vLcd8WA7pumu2I89IFtF3bvHWXBqUSoub8m4n_fH8AfqJSIg</recordid><startdate>202207</startdate><enddate>202207</enddate><creator>Figueres, Lucile</creator><creator>Bruneau, Sarah</creator><creator>Prot-Bertoye, Caroline</creator><creator>Brideau, Gaëlle</creator><creator>Néel, Mélanie</creator><creator>Griveau, Camille</creator><creator>Cheval, Lydie</creator><creator>Bignon, Yohan</creator><creator>Dimitrov, Jordan</creator><creator>Dejoie, Thomas</creator><creator>Ville, Simon</creator><creator>Kandel-Aznar, Christine</creator><creator>Moreau, Anne</creator><creator>Houillier, Pascal</creator><creator>Fakhouri, Fadi</creator><general>American Society of Nephrology</general><scope>1XC</scope><orcidid>https://orcid.org/0000-0003-0618-6187</orcidid><orcidid>https://orcid.org/0000-0002-1552-0725</orcidid><orcidid>https://orcid.org/0000-0002-1473-2064</orcidid><orcidid>https://orcid.org/0000-0001-8536-8995</orcidid><orcidid>https://orcid.org/0000-0002-1473-2064</orcidid><orcidid>https://orcid.org/0000-0001-8536-8995</orcidid><orcidid>https://orcid.org/0000-0002-1552-0725</orcidid><orcidid>https://orcid.org/0000-0003-0618-6187</orcidid></search><sort><creationdate>202207</creationdate><title>Hypomagnesemia, Hypocalcemia, and Tubulointerstitial Nephropathy Caused by Claudin-16 Autoantibodies</title><author>Figueres, Lucile ; Bruneau, Sarah ; Prot-Bertoye, Caroline ; Brideau, Gaëlle ; Néel, Mélanie ; Griveau, Camille ; Cheval, Lydie ; Bignon, Yohan ; Dimitrov, Jordan ; Dejoie, Thomas ; Ville, Simon ; Kandel-Aznar, Christine ; Moreau, Anne ; Houillier, Pascal ; Fakhouri, Fadi</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-hal_primary_oai_HAL_hal_04733822v13</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Life Sciences</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Figueres, Lucile</creatorcontrib><creatorcontrib>Bruneau, Sarah</creatorcontrib><creatorcontrib>Prot-Bertoye, Caroline</creatorcontrib><creatorcontrib>Brideau, Gaëlle</creatorcontrib><creatorcontrib>Néel, Mélanie</creatorcontrib><creatorcontrib>Griveau, Camille</creatorcontrib><creatorcontrib>Cheval, Lydie</creatorcontrib><creatorcontrib>Bignon, Yohan</creatorcontrib><creatorcontrib>Dimitrov, Jordan</creatorcontrib><creatorcontrib>Dejoie, Thomas</creatorcontrib><creatorcontrib>Ville, Simon</creatorcontrib><creatorcontrib>Kandel-Aznar, Christine</creatorcontrib><creatorcontrib>Moreau, Anne</creatorcontrib><creatorcontrib>Houillier, Pascal</creatorcontrib><creatorcontrib>Fakhouri, Fadi</creatorcontrib><collection>Hyper Article en Ligne (HAL)</collection><jtitle>Journal of the American Society of Nephrology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Figueres, Lucile</au><au>Bruneau, Sarah</au><au>Prot-Bertoye, Caroline</au><au>Brideau, Gaëlle</au><au>Néel, Mélanie</au><au>Griveau, Camille</au><au>Cheval, Lydie</au><au>Bignon, Yohan</au><au>Dimitrov, Jordan</au><au>Dejoie, Thomas</au><au>Ville, Simon</au><au>Kandel-Aznar, Christine</au><au>Moreau, Anne</au><au>Houillier, Pascal</au><au>Fakhouri, Fadi</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Hypomagnesemia, Hypocalcemia, and Tubulointerstitial Nephropathy Caused by Claudin-16 Autoantibodies</atitle><jtitle>Journal of the American Society of Nephrology</jtitle><date>2022-07</date><risdate>2022</risdate><volume>33</volume><issue>7</issue><spage>1402</spage><epage>1410</epage><pages>1402-1410</pages><issn>1046-6673</issn><eissn>1533-3450</eissn><abstract>Significant Statement Chronic hypomagnesemia is commonly due to diarrhea, alcoholism, and drugs; more rarely, genetic defects in the effectors of renal magnesium reabsorption are responsible. The authors report on an adult patient with acquired severe hypomagnesemia, hypocalcemia, and tubulointerstitial nephropathy, with rapidly progressing kidney injury. In in vivo and in vitro studies, they found evidence of a causal link between the patient’s condition and autoantibodies against claudin-16, a transmembrane paracellular protein involved in renal magnesium absorption. The patient was subsequently diagnosed with a renal carcinoma that expressed a high level of claudin-16 mRNA. Pathogenic claudin-16 autoantibodies represent a novel autoimmune cause of specific renal tubular transport disturbances and tubulointerstitial nephropathy. Screening for autoantibodies targeting claudin-16 and potentially other renal magnesium transporters or channels may be warranted in patients with acquired unexplained hypomagnesemia. Background Chronic hypomagnesemia is commonly due to diarrhea, alcoholism, and drugs. More rarely, it is caused by genetic defects in the effectors of renal magnesium reabsorption. Methods In an adult patient with acquired severe hypomagnesemia, hypocalcemia, tubulointerstitial nephropathy, and rapidly progressing kidney injury, similarities between the patient’s presentation and features of genetic disorders of renal magnesium transport prompted us to investigate whether the patient had an acquired autoimmune cause of renal magnesium wasting. To determine if the patient’s condition might be explained by autoantibodies directed against claudin-16 or claudin-19, transmembrane paracellular proteins involved in renal magnesium absorption, we conducted experiments with claudin knockout mice and transfected mouse kidney cells expressing human claudin-16 or claudin-19. We also examined effects on renal magnesium handling in rats given intravenous injections of IgG purified from sera from the patient or controls. Results Experiments with the knockout mice and in vitro transfected cells demonstrated that hypomagnesemia in the patient was causally linked to autoantibodies directed against claudin-16, which controls paracellular magnesium reabsorption in the thick ascending limb of Henle’s loop. Intravenous injection of IgG purified from the patient’s serum induced a marked urinary waste of magnesium in rats. Immunosuppressive treatment combining plasma exchange and rituximab was associated with improvement in the patient’s GFR, but hypomagnesemia persisted. The patient was subsequently diagnosed with a renal carcinoma that expressed a high level of claudin-16 mRNA. Conclusions Pathogenic claudin-16 autoantibodies represent a novel autoimmune cause of specific renal tubular transport disturbances and tubulointerstitial nephropathy. Screening for autoantibodies targeting claudin-16, and potentially other magnesium transporters or channels in the kidney, may be warranted in patients with acquired unexplained hypomagnesemia.</abstract><pub>American Society of Nephrology</pub><pmid>35728884</pmid><doi>10.1681/ASN.2022010060</doi><orcidid>https://orcid.org/0000-0003-0618-6187</orcidid><orcidid>https://orcid.org/0000-0002-1552-0725</orcidid><orcidid>https://orcid.org/0000-0002-1473-2064</orcidid><orcidid>https://orcid.org/0000-0001-8536-8995</orcidid><orcidid>https://orcid.org/0000-0002-1473-2064</orcidid><orcidid>https://orcid.org/0000-0001-8536-8995</orcidid><orcidid>https://orcid.org/0000-0002-1552-0725</orcidid><orcidid>https://orcid.org/0000-0003-0618-6187</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 1046-6673
ispartof Journal of the American Society of Nephrology, 2022-07, Vol.33 (7), p.1402-1410
issn 1046-6673
1533-3450
language eng
recordid cdi_hal_primary_oai_HAL_hal_04733822v1
source PubMed Central; EZB Electronic Journals Library
subjects Life Sciences
title Hypomagnesemia, Hypocalcemia, and Tubulointerstitial Nephropathy Caused by Claudin-16 Autoantibodies
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-13T18%3A09%3A28IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-hal&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Hypomagnesemia,%20Hypocalcemia,%20and%20Tubulointerstitial%20Nephropathy%20Caused%20by%20Claudin-16%20Autoantibodies&rft.jtitle=Journal%20of%20the%20American%20Society%20of%20Nephrology&rft.au=Figueres,%20Lucile&rft.date=2022-07&rft.volume=33&rft.issue=7&rft.spage=1402&rft.epage=1410&rft.pages=1402-1410&rft.issn=1046-6673&rft.eissn=1533-3450&rft_id=info:doi/10.1681/ASN.2022010060&rft_dat=%3Chal%3Eoai_HAL_hal_04733822v1%3C/hal%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/35728884&rfr_iscdi=true